Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Deep Longevity Adds Partnership with My Care Express in Merrillville To Add Biomarkers of Aging and Longevity 2020-11-26 16:00
Gustaf Salford appointed Elekta CEO by Board of Directors 2020-11-26 14:59
RhoVac's Prostate Cancer Drug Candidate, RV001, is granted Fast Track Designation by the FDA 2020-11-25 16:06
MedAlliance announces successful completion of enrolment in ISABELLA clinical trial for the treatment of failing AV fistulas in hemodialysis patients 2020-11-25 08:00
RedHill Biopharma to Present at Evercore ISI HealthCONx and Piper Sandler Healthcare Conferences 2020-11-25 07:00
Almirall announces collaborations with the University of South Australia and Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 2020-11-25 06:00
China Biologic Reports Financial Results for the Third Quarter of 2020 2020-11-25 05:30
Global Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2021 2020-11-25 05:16
NaviFUS highlights clinical trial data and device capabilities at virtual International Focused Ultrasound Symposium 2020-11-24 22:26
OliPass Announces Formation of Scientific Advisory Board of Pioneers in Sodium Ion Channellopathy and Pain 2020-11-24 22:00
New Centre for Medicines Research (CMR) Clinical Factbook From Clarivate Highlights Increasing Cost and Complexity of Phase II Trials 2020-11-24 16:05
Sunway University Researcher Looks into Genomes and Allergies 2020-11-24 09:00
Koru Lifescience preparing to send drug compounds to preclinical and clinical trials based on their study for Covid-19 2020-11-24 04:35
3SBio Inc. received milestone payment of USD 4 million upon commencement of phase III clinical program of SEL-212 2020-11-23 21:28
Creation of a research partnership between Pierre Fabre and Y-Biologics for the development of new immunotherapies based on monoclonal antibodies 2020-11-23 09:00
Antengene Corporation, an Innovative Cancer Biotech Company, is Listed on the Main Board of the Hong Kong Stock Exchange 2020-11-20 21:09
RedHill Biopharma Initiates Phase 3 Study of RHB-204 for First-Line Treatment of NTM Disease 2020-11-20 21:00
WuXi Biologics Launched Biologics Integrated Innovation Center in Hangzhou 2020-11-20 16:30
WPI-MANA Team: Biogenic Iron Sulfide Nanoparticles Enable Electron Uptake in Bacteria 2020-11-20 14:00
RedHill Biopharma's Second COVID-19 Candidate, RHB-107, Cleared by FDA for Phase 2/3 Study in Symptomatic COVID-19 Disease 2020-11-20 07:00
1 229 230 231 232 233 412